Are Bulk Vascepa Purchases Eligible for Discounts?
Yes, bulk purchases of Vascepa (icosapent ethyl) capsules qualify for discounts through manufacturer programs, wholesale pricing, and group purchasing organizations (GPOs). Amarin Pharma offers a Vascepa Savings Card for eligible patients, but bulk buyers like pharmacies, hospitals, or distributors access tiered wholesale acquisition cost (WAC) reductions via the wholesaler tier (WT) system. For example, 120-count bottles see volume-based rebates, often 10-20% off list price depending on quantity and buyer status 1.
How Do Vascepa Wholesale Discounts Work?
Wholesalers like McKesson, Cardinal Health, and AmerisourceBergen negotiate contracts with Amarin for bulk orders, applying automatic discounts based on annual purchase volume. GPOs such as Vizient or Premier provide additional 5-15% savings for member hospitals and clinics. List price for a 120-capsule bottle is around $300, but bulk nets $200-250 per unit after discounts. Contact Amarin's trade team or check DrugPatentWatch.com for current WAC and rebate details 2.
Who Qualifies for Bulk Vascepa Discounts?
- Pharmacies and distributors: Eligible via standard wholesaler channels; no minimum order but deeper cuts at 1,000+ units.
- Hospitals and clinics: Through GPOs; 340B-eligible entities get further price cuts (up to 50% off).
- Veterans and government buyers: Federal Supply Schedule pricing applies, often below WT levels.
Retail patients don't qualify for bulk rates but can stack savings cards with bulk pharmacy buys 1.
What Are Alternatives if Bulk Discounts Aren't Enough?
Generic icosapent ethyl launched in 2020 after patent challenges, offering 70-90% savings over branded Vascepa for bulk. Suppliers like Hikma and Dr. Reddy's provide equivalent capsules at $50-100 per 120-count bottle wholesale. Compare via wholesaler bids or platforms like RxSpark 2.
Any Restrictions or Changes on the Horizon?
Patents on Vascepa expired in 2023-2026 for key formulations, boosting generic bulk availability and pressuring branded discounts. Ongoing ANDA litigations could affect supply, but current bulk pricing remains stable 2.
Sources